(Reuters) - Allergan Inc, known best for its Botox wrinkle treatment, said on Friday that European Union regulators had recommended use of its eye drug Ozurdex be extended to treat patients with diabetic macular edema. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/XUNGOnceToM/story01.htm
Read More
No comments:
Post a Comment